Alaunos Therapeutics (TCRT) Capital Expenditures Growth (1y) (2010 - 2023)
Alaunos Therapeutics (TCRT) Capital Expenditures Growth (1y) (2010 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Alaunos Therapeutics |
4.31 Mn |
3.95 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2023 |
-92.86% |
| Jun 30, 2023 |
136.84% |
| Mar 31, 2023 |
110.34% |
| Dec 31, 2022 |
-67.69% |
| Sep 30, 2022 |
-96.22% |
| Jun 30, 2022 |
-97.02% |
| Mar 31, 2022 |
-95.75% |
| Dec 31, 2021 |
-90.47% |
| Sep 30, 2021 |
-92.58% |
| Jun 30, 2021 |
272.71% |
| Mar 31, 2021 |
32.94% |
| Dec 31, 2020 |
3,666.00% |
| Sep 30, 2020 |
4,559.81% |
| Jun 30, 2020 |
665.67% |
| Mar 31, 2020 |
5,030.00% |
| Dec 31, 2019 |
216.28% |
| Sep 30, 2019 |
-36.69% |
| Jun 30, 2019 |
-70.35% |
| Mar 31, 2019 |
-93.33% |
| Dec 31, 2018 |
-131.16% |
